摘要
目的研究环磷酸腺苷(cAMP)/蛋白激酶A通路与谷氨酰胺刺激胰岛素分泌机制的相关性。方法按照细胞培养标准操作规程培养15HC9细胞(一种来源于转基因鼠的B细胞株),在有葡萄糖(0.25mmoL/L)存在的前提下,以不同浓度的谷氨酰胺(0.0、0.5、1.0、2.0、5.0mmol/L)刺激13HC9细胞胰岛素的分泌,取出培养液,离心后留取上清液,分别测定细胞培养液中的胰岛素水平和13HC9细胞内的cAMP水平,分析谷氨酰胺刺激对15HC9细胞内cAMP水平和培养液中胰岛素水平的影响。结果在有葡萄糖(0.25mmol/L)存在的前提下,随着谷氨酰胺浓度的增加(0.0、0.5、1.0、2.0、5.0mmolfL),13HC9细胞培养液中的胰岛素[0.0ng/(mL·million)、19.1ng/(mL·million)、29.1ng/(mL·million)、30.1rig/(mL·million)、33.9us/(mL·million)]及cAMP水平(0.0pmol/million、40.0pmol/million、51.5pmol/million、52.5pmol/million、61.3pmol/million)均相应增加。结论谷氨酰胺对葡萄糖刺激的胰岛素分泌起着进一步放大作用,并且这种放大作用是以cAMP的存在为前提的。
Objective To study the relationship between cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway and glutamine-stimulated insulin secretion. Methods In the prerequisite of the existence of glucose(0.25 mmol/L), the insulin secretion of I3HC9 cells was stimulated with different concentrations of glutamine ( 0.0,0.5,1.0,2.0,5.0 mmol/L), then culture liquids were extracted and centrifugalized, and the insulin levels in the cell culture liquids and the cAMP levels in I3HC9 cells were determined, so as to study the effects of glutamine stimula- tion on the insulin level in cell culture liquids and cAMP levels in [3HC9 cells were assayed. Results In the prerequi- site of the glucose existence,with the increasing of the concentrations of glutamine(0.0,0.5,1.0,2.0,5.0 mmol/L) , the insulin levels[0.0 ng/( mE million), 19.1 ng/( mL ~ million) ,29.1 rig/( mL million) ,30.1 rig/( mL mil- lion) ,33.9 ng/( mL million)] in cell culture liquids and the cAMP levels (0.0 pmol/million, 40.0 pmol/million, 51.5 pmol/million,52.5 pmol/million,61.3 pmol/million) in 13HC9 cells increased accordingly. Conclusion Gluta- mine has amplifying effect on glucose stimulated insulin secretion, such amplifying effect needs the existence of cAMP to be prerequisite.
出处
《中华实用儿科临床杂志》
CAS
CSCD
北大核心
2013年第20期1537-1539,共3页
Chinese Journal of Applied Clinical Pediatrics
基金
国家自然科学基金委员会主任基金(81041015)
关键词
胰岛素分泌
谷氨酰胺
环磷酸腺苷
蛋白激酶A通路
Insulin secretion
Glutamine
Cyclic adenosine monophosphate/protein kinase A pathway